Raymond James Financial Services Advisors, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$490,604
+98.6%
5,396
+119.5%
0.00%0.0%
Q3 2021$247,000
-22.6%
2,458
+9.1%
0.00%0.0%
Q2 2021$319,000
+20.8%
2,252
-15.1%
0.00%0.0%
Q1 2021$264,000
+18.4%
2,651
+47.2%
0.00%0.0%
Q4 2020$223,000
-34.2%
1,801
-17.2%
0.00%0.0%
Q2 2020$339,0002,1750.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CPMG Inc 3,063,567$298,453,00049.63%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 150,000$14,613,00019.62%
Corriente Advisors, LLC 300,000$29,226,00014.82%
Prosight Management, LP 114,554$11,160,0005.31%
MADDEN SECURITIES Corp 43,927$4,279,0003.18%
LBJ Family Wealth Advisors, Ltd. 30,368$2,958,0002.24%
Biondo Investment Advisors, LLC 99,652$9,708,0002.10%
Cormorant Asset Management, LP 450,000$43,839,0001.69%
Duquesne Family Office 543,901$52,987,0001.54%
AWH Capital, L.P. 9,500$925,0001.30%
View complete list of REATA PHARMACEUTICALS INC shareholders